A detailed history of Quantum Private Wealth, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Quantum Private Wealth, LLC holds 7,205 shares of KRYS stock, worth $1.27 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
7,205
Previous 7,205 -0.0%
Holding current value
$1.27 Million
Previous $1.28 Million 3.28%
% of portfolio
0.49%
Previous 0.49%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

BUY
$64.85 - $82.4 $64,849 - $82,400
1,000 Added 16.12%
7,205 $502,000
Q2 2022

Aug 17, 2022

SELL
$48.93 - $73.47 $8,660 - $13,004
-177 Reduced 2.77%
6,205 $407,000
Q1 2022

May 27, 2022

SELL
$51.99 - $72.11 $22,979 - $31,872
-442 Reduced 6.48%
6,382 $424,000
Q4 2021

May 26, 2022

BUY
$39.81 - $88.24 $271,663 - $602,149
6,824 New
6,824 $477,000

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.54B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Quantum Private Wealth, LLC Portfolio

Follow Quantum Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantum Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantum Private Wealth, LLC with notifications on news.